Cybin CYBN Stock
Cybin Price Chart
Cybin CYBN Financial and Trading Overview
Cybin stock price | 6.87 USD |
Previous Close | 0.25 USD |
Open | 0.25 USD |
Bid | 0.25 USD x 800 |
Ask | 0.25 USD x 1400 |
Day's Range | 0.25 - 0.28 USD |
52 Week Range | 0.21 - 1.14 USD |
Volume | 2.78M USD |
Avg. Volume | 1.3M USD |
Market Cap | 52.73M USD |
Beta (5Y Monthly) | 1.88952 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -3.57 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 4.38 USD |
CYBN Valuation Measures
Enterprise Value | 26.4M USD |
Trailing P/E | N/A |
Forward P/E | -1.375 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | N/A |
Price/Book (mrq) | 0.9322035 |
Enterprise Value/Revenue | N/A |
Enterprise Value/EBITDA | -0.489 |
Trading Information
Cybin Stock Price History
Beta (5Y Monthly) | 1.88952 |
52-Week Change | -51.83% |
S&P500 52-Week Change | 20.43% |
52 Week High | 1.14 USD |
52 Week Low | 0.21 USD |
50-Day Moving Average | 0.31 USD |
200-Day Moving Average | 0.44 USD |
CYBN Share Statistics
Avg. Volume (3 month) | 1.3M USD |
Avg. Daily Volume (10-Days) | 2.32M USD |
Shares Outstanding | 191.76M |
Float | 156.66M |
Short Ratio | 2.43 |
% Held by Insiders | 22.28% |
% Held by Institutions | 7.86% |
Shares Short | 2.92M |
Short % of Float | N/A |
Short % of Shares Outstanding | 1.52% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 149:1000 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | March 31, 2022 |
Most Recent Quarter (mrq) | December 31, 2022 |
Next Fiscal Year End | March 31, 2023 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | 0% |
Gross Margin | 0% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -43.43% |
Return on Equity (ttm) | -71.33% |
Income Statement
Revenue (ttm) | N/A |
Revenue Per Share (ttm) | N/A |
Quarterly Revenue Growth (yoy) | N/A |
Gross Profit (ttm) | N/A |
EBITDA | -53938000 USD |
Net Income Avi to Common (ttm) | -51867000 USD |
Diluted EPS (ttm) | -0.23 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 22.64M USD |
Total Cash Per Share (mrq) | 0.12 USD |
Total Debt (mrq) | 0 USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 6.891 |
Book Value Per Share (mrq) | 0.295 |
Cash Flow Statement
Operating Cash Flow (ttm) | -46314000 USD |
Levered Free Cash Flow (ttm) | -32884624 USD |
Profile of Cybin
Country | United States |
State | ON |
City | Toronto |
Address | 100 King Street West |
ZIP | M5X 1C9 |
Phone | N/A |
Website | https://www.cybin.com |
Industry | Biotechnology |
Sector(s) | Healthcare |
Full Time Employees | 50 |
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to treat neuroinflammation. It has also developed EMBARK, a psychedelic-assisted psychotherapy. The company is headquartered in Toronto, Canada.
Q&A For Cybin Stock
What is a current CYBN stock price?
Cybin CYBN stock price today per share is 6.87 USD.
How to purchase Cybin stock?
You can buy CYBN shares on the NYSE American exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Cybin?
The stock symbol or ticker of Cybin is CYBN.
Which industry does the Cybin company belong to?
The Cybin industry is Biotechnology.
How many shares does Cybin have in circulation?
The max supply of Cybin shares is 21.49M.
What is Cybin Price to Earnings Ratio (PE Ratio)?
Cybin PE Ratio is now.
What was Cybin earnings per share over the trailing 12 months (TTM)?
Cybin EPS is -3.57 USD over the trailing 12 months.
Which sector does the Cybin company belong to?
The Cybin sector is Healthcare.